Medical Research News and Research

RSS

Study: Non-medical cannabis use is more common in adults suffering from pain

A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons found that non-medical cannabis use--including frequent or problematic use--is significantly more common in adults with pain than in those without pain.

22 Jan 2020

Potential Parkinson's treatment effectively targets a specific group of brain cells

Scientists have discovered that a non-invasive technique which could one day be used to treat Parkinson's disease, can successfully target a highly specific group of brain cells which play a key role in development of the condition.

22 Jan 2020

George Mason University researchers receive $314,000 to design better vaccines

George Mason University's Aarthi Narayanan, Associate Professor, College of Science and the National Center for Biodefense and Infectious Disease, and Remi Veneziano, Assistant Professor, Volgenau School of Engineering, received $314,000 from U.S. Army Medical Research Acquisition Activity for a project researching DNA-nanoparticles and vaccine design.

21 Jan 2020

New genetic test to predict and prevent vision loss from glaucoma

Researchers have identified 107 genes that increase a person's risk of developing the eye disease glaucoma, and now developed a genetic test to detect those at risk of going blind from it.

21 Jan 2020

FDA-approved medication for opioid addiction is increasing except in the youngest group

An analysis of national data on buprenorphine use found that treatment with the FDA-approved medication for opioid addiction is increasing in all age groups except the young (age 15-24 years), in whom use of the medication is decreasing.

21 Jan 2020

Breakthrough discovery could lead to more effective immunotherapies

Scientists at UCL have discovered how immune cells, essential for tackling life-threatening infections and cancers, are able to 'recycle' material within themselves in order to stay healthy and function, a breakthrough finding which could lead to more effective immunotherapies.

21 Jan 2020

Discovery of metabolic system could lead to new strategies for cancer treatment

Australian researchers have uncovered a metabolic system which could lead to new strategies for therapeutic cancer treatment.

21 Jan 2020

Research suggests new approach to reducing the risk of sudden death in heart failure

Around 26 million people worldwide suffer from heart failure, with more than 50 per cent dying suddenly most likely due to the spontaneous onset of a heart rhythm problem, known as an arrhythmia.

20 Jan 2020

Prenatal alcohol and tobacco exposure linked to increased risk for SIDS

Children born to mothers who both drank and smoked beyond the first trimester of pregnancy have a 12-fold increased risk for Sudden Infant Death Syndrome (SIDS) compared to those unexposed or only exposed in the first trimester of pregnancy, according to a new study supported by the National Institutes of Health.

20 Jan 2020

Psychedelics could help treat trauma-related disorders

Clinical trials suggest treatment that involves psychedelics can be more effective than psychotherapy alone.

17 Jan 2020

Inexpensive drug may be used to counteract treatment resistance in patients with leukemia

A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia, one of the most common forms of blood cancer.

17 Jan 2020

Greater medical care needed for older adults with untreated sleep apnea

Obstructive sleep apnea is a common and costly medical condition leading to a wide range of health risks such as cardiovascular disease, stroke, depression, diabetes and even premature death.

16 Jan 2020

3D structure of DNA is 'rewired' in hormone-resistant ER+ breast cancers

Epigenetic changes occur in the DNA of breast cancer cells that have developed a resistance to hormone therapy, an effective treatment for ER+ breast cancer, which accounts for 70% of all diagnoses.

16 Jan 2020

Research collaboration reveals potential treatment option for incurable blood cancers

Today, OncoTartis, Inc. and Children's Cancer Institute jointly announced the publication of two research manuscripts in a leading onco-hematological journal Leukemia, both devoted to the OncoTartis' clinical drug candidate OT-82.

16 Jan 2020

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

A stem cell transplant - also called a bone marrow transplant - is a common treatment for blood cancers, such as acute myeloid leukemia.

16 Jan 2020

Blue light exposure therapy can aid in healing people with mTBI

Early morning blue light exposure therapy can aid the healing process of people impact by mild traumatic brain injury, according to new research from the University of Arizona.

16 Jan 2020

Essential tremor caused by overactive brain waves

The source of essential tremor--a movement disorder that causes involuntary trembling of the hands, arms, and head--has been enigmatic, impeding the development of effective treatments for a condition that affects 4% of people over 40.

16 Jan 2020

First randomized clinical trial finds no harm from population screening for dementia

Research scientists at Regenstrief Institute and Indiana University School of Medicine have conducted the first randomized controlled trial to evaluate the pros and cons of population screening for dementia.

16 Jan 2020

Protein SV2A levels could explain poor neuronal connections in schizophrenia

A team of researchers have found that persons with schizophrenia may have lower levels of certain specific proteins that show up on their brain scans. This could help as diagnostic tools, say experts. The new study titled, “Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats”, is published in the latest issue of the journal Nature Communications.

14 Jan 2020

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute reveals how a clotting protein and blood platelets can promote cancer progression and suppress immune responses to cancer.

14 Jan 2020

Medical Research News and Research

Study: Non-medical cannabis use is more common in adults suffering from pain

Potential Parkinson's treatment effectively targets a specific group of brain cells

George Mason University researchers receive $314,000 to design better vaccines

New genetic test to predict and prevent vision loss from glaucoma

FDA-approved medication for opioid addiction is increasing except in the youngest group

Breakthrough discovery could lead to more effective immunotherapies

Discovery of metabolic system could lead to new strategies for cancer treatment

Research suggests new approach to reducing the risk of sudden death in heart failure

Prenatal alcohol and tobacco exposure linked to increased risk for SIDS

Psychedelics could help treat trauma-related disorders

Inexpensive drug may be used to counteract treatment resistance in patients with leukemia

Greater medical care needed for older adults with untreated sleep apnea

3D structure of DNA is 'rewired' in hormone-resistant ER+ breast cancers

Research collaboration reveals potential treatment option for incurable blood cancers

Harmful genetic mutations in healthy donors' stem cells may create problems in AML patients

Blue light exposure therapy can aid in healing people with mTBI

Essential tremor caused by overactive brain waves

First randomized clinical trial finds no harm from population screening for dementia

Protein SV2A levels could explain poor neuronal connections in schizophrenia

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News